Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study
Reports and Proceedings
Updates every hour. Last Updated: 29-Dec-2025 03:11 ET (29-Dec-2025 08:11 GMT/UTC)